START2 Life Sciences
ENABLING HEALTHTECH STARTUPS TO DE-RISK, GROW, AND SCALE INTERNATIONALLY
We understand the many challenges and intricacies of the health tech market.
With our experience, network and market know how, we provide fast and efficient solutions.
Explore your chances in a new market, test your products and services, understand the regulatory requirements and get funding - these are the essential milestones to scale and progress, without losing valuable time.
We support you in the following areas to make your market entry a success:
Access to new customers,
industry and clinical partners.
We open doors!
Guidance on regulations and compliance
We provide transparency!
Find funding, grants and other resources.
We build momentum!
Our Solutions and Support
Foothold Market Identification
Learn about clinical decision-making, reimbursement, insurance, and driving forces of market stakeholders
Market and Clinical Validation
Identify and access appropriate users, buyers, and partners to validate benefits and value proposition, and to understand adoption hurdles
Regulatory Approval Path
Develop regulatory strategy and plan: classification, claims, target patient population, and study design
Investment Readiness
Develop compelling investment thesis and narrative for healthtech-specific investors and corporate partners
Our Projects and Partnerships
Accelerating the Next Generation of Therapeutic and Vaccine Platforms and Technologies.
VITAL is a new accelerator hub in the U.S. Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network (BAN).
Start2 Life Sciences Programs
· Highly Customized
· High-Touch
· Hybrid
Individualized engagements intensely focused on market validation, access and exploration
Dedicated lead mentor, project manager, and extended mentor team for each company
85+ active mentors – commercialization experts, investors, clinicians, entrepreneurs
Support from seed to series A in therapeutics, diagnostics, digital health, devices, platforms and more
Success Stories
- Small molecule therapeutics for oncology and infectious disease
- 8 months Start2 Mentor support (recent graduate)
- Result: Robust development plan, compelling US investor deck
- D-peptide therapeutics for psychic disorders (anxiety/PTSD)
- 8 months Start2 Mentor support (recent graduate)
- Result: Robust development plan
- D-peptide therapeutics for neurological disorders
- 7 months Start2 Mentor support (recent graduate)
- Result: Compelling investment deck for US investors and US SAB
- Next generation antibody drug conjugate (ADCs)
- 9 months Start2 Mentor support
- Result: €60M B round investment, strategic license with Bristol Meyers Squibb
- Vaccines for infectious diseases and cancer treatment
- Result: €43M investment, strategic collaboration with Boehringer Ingelheim
Experienced and Impactful Mentors Enable Successful Scaling
Sr. Medical Director
Columbia University Medical Center
Founder & Managing Director
EXXclaim Capital
CEO
Dragonfly Innovations
Managing Partner
Wave Strategy LLC
President
Cephos LLC
Managing Director
HUB Angels
CEO & CSO
Trueline Therapeutics
MD of Innovation
Blue Cross Blue Shield of MA
Life Sciences Programs
Supercharge Your Biotech Startup in the U.S. Market.
Succeed in the competitive U.S. market